Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.

Canova L, Alimenti E, Argiento L, Cabibbo G, Tovoli F, Di Giacomo E, Galle PR, Celsa C, Pinter M, Marron TU, Vivaldi C, Dalbeni A, Marra F, Palloni A, Lonardi S, Ponziani FR, Federico P, Saeed A, Pillai A, Pressiani T, Camera S, Svegliati-Baroni G, Manfredi GF, Lani L, von Felden J, Ulahannan S, Ielasi L, De Lorenzo S, Mazzarelli C, Sacco R, Rohlen N, Silletta M, Toniutto P, Ascari S, Fulgenzi C, Scheiner B, Crowley F, Cerini F, Lampertico P, Pinato DJ, Iavarone M

Open source

DOI
10.1016/j.cgh.2026.04.033
Published
2026 May 26
Container
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cgh.2026.04.033,
  title = {Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.},
  author = {Canova L and Alimenti E and Argiento L and Cabibbo G and Tovoli F and Di Giacomo E and Galle PR and Celsa C and Pinter M and Marron TU and Vivaldi C and Dalbeni A and Marra F and Palloni A and Lonardi S and Ponziani FR and Federico P and Saeed A and Pillai A and Pressiani T and Camera S and Svegliati-Baroni G and Manfredi GF and Lani L and von Felden J and Ulahannan S and Ielasi L and De Lorenzo S and Mazzarelli C and Sacco R and Rohlen N and Silletta M and Toniutto P and Ascari S and Fulgenzi C and Scheiner B and Crowley F and Cerini F and Lampertico P and Pinato DJ and Iavarone M},
  year = {2026},
  journal = {Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association},
  doi = {10.1016/j.cgh.2026.04.033},
  url = {https://doi.org/10.1016/j.cgh.2026.04.033}
}

RIS

TY  - JOUR
TI  - Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
AU  - Canova L
AU  - Alimenti E
AU  - Argiento L
AU  - Cabibbo G
AU  - Tovoli F
AU  - Di Giacomo E
AU  - Galle PR
AU  - Celsa C
AU  - Pinter M
AU  - Marron TU
AU  - Vivaldi C
AU  - Dalbeni A
AU  - Marra F
AU  - Palloni A
AU  - Lonardi S
AU  - Ponziani FR
AU  - Federico P
AU  - Saeed A
AU  - Pillai A
AU  - Pressiani T
AU  - Camera S
AU  - Svegliati-Baroni G
AU  - Manfredi GF
AU  - Lani L
AU  - von Felden J
AU  - Ulahannan S
AU  - Ielasi L
AU  - De Lorenzo S
AU  - Mazzarelli C
AU  - Sacco R
AU  - Rohlen N
AU  - Silletta M
AU  - Toniutto P
AU  - Ascari S
AU  - Fulgenzi C
AU  - Scheiner B
AU  - Crowley F
AU  - Cerini F
AU  - Lampertico P
AU  - Pinato DJ
AU  - Iavarone M
PY  - 2026
JO  - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
DO  - 10.1016/j.cgh.2026.04.033
UR  - https://doi.org/10.1016/j.cgh.2026.04.033
ER  -

APA

L, C., E, A., L, A., G, C., F, T., E, D. G., PR, G., C, C., M, P., TU, M., C, V., A, D., F, M., A, P., S, L., FR, P., P, F., A, S., A, P., T, P., S, C., G, S., GF, M., L, L., J, V. F., S, U., L, I., S, D. L., C, M., R, S., N, R., M, S., P, T., S, A., C, F., B, S., F, C., F, C., P, L., DJ, P., & M, I. (2026). Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. https://doi.org/10.1016/j.cgh.2026.04.033

Source records